Roger Lias is a seasoned C-suite executive and business development leader with a distinguished track record in the biopharmaceutical industry. With deep experience spanning both contract services and traditional pharmaceutical business development—including M&A and licensing—Roger brings a unique blend of strategic insight, deal-making expertise, and operational leadership. Known for his entrepreneurial mindset and creative problem-solving, Roger has led start-ups, guided high-growth ventures, and driven transformational initiatives within multinational biopharma environments. His strong leadership and communication skills have enabled him to build and inspire high-performing teams across global markets. A recognized international authority in the biologics CDMO space, Roger is a veteran of start-up, growth, and turnaround strategies. His work has consistently delivered measurable value and accelerated growth for organizations worldwide. He also maintains a global network of influential contacts across biotech, pharma, technology, and the financial sectors—relationships that continue to inform and enhance his strategic approach. With a reputation for innovation, execution, and results, Roger remains at the forefront of shaping the future of outsourced pharmaceutical development and manufacturing.
